KORONIS IN THE NEWS

From Soup to Nuts
Drug Discovery & Development, April 01, 2008

Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
Press Release, Koronis Pharmaceuticals, February 7, 2008

Why Are Evolutionary Biologists Bringing Back Extinct Deadly Viruses?
The New Yorker, Annals of Science, Darwin’s Surprise, December 3, 2007


Koronis Pharmaceuticals develops anti-viral therapeutics based on Viral Decay Acceleration™™ (VDA). The Company's lead product candidate is KP-1461 for the treatment of HIV. Koronis does not currently have any clinical trials open for patient enrollment.